Table 3.
Main Effect and Interaction Effect of Non-Medical Prescription Opioid Use (NMPOU) and Race on Suicidality (n=38,088)†
| Serious Thoughts of Suicide | Have a Plan for Suicide | Suicide Attempts | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Those With NMPOU | Those Without NMPOU | OR (95% CI) | Those With NMPOU | Those Without NMPOU | OR (95% CI) | Those With NMPOU | Those Without NMPOU | OR (95% CI) | |
|
| |||||||||
| Non-Medical Prescription Opioid Use b | 16.0% | 5.5% | 1.00 (0.77; 1.30) | 7.7% | 2.0% | 1.24 (0.86; 1.79) | 3.9% | 0.8% | 1.41 (0.84; 2.37) |
| Have 1 or More Disability b | 12.6% | 4.2% | 1.13 (0.94; 1.37) | 5.5% | 1.3% | 1.28 (1.03; 1.58)* | 3.9% | 1.3% | 1.72 (1.30; 2.29)*** |
| No Disability (Ref) | 9.8% | 4.1% | -- | 3.9% | 1.3% | -- | 2.5% | 0.7% | -- |
| Non-Medical Prescription Opioid Use x Disabled | 1.47 (1.01; 2.12)* | 1.89 (1.23; 2.92)** | 2.57 (1.30; 5.09)** | ||||||
| Pseudo R2 | 0.34a | 0.29a | 0.25a | ||||||
| Wald Statistic F Statistic (df) | 68.81*** (43, 8) | 50.41*** (43, 8) | 59.04*** (43, 8) | ||||||
p-value <0.05
p-value <0.01
p-value <0.001
All analyses controlled for socio-demographics, other substance use (binge drinking, cannabis, heroin, fentanyl, cocaine, crack cocaine, inhalants, hallucinogens, methamphetamine, stimulants, tranquilizers, sedatives), self-rated health, and mental health (past-year major depressive episode, psychological distress, mental health impairment). Estimates from these variables can be furnished upon request.
Pseudo R2 was not estimated with survey design weights due to issues of heteroskedasticity. The Pseudo R2 value presented here is unweighted.
The main effects reported here in Table 3 are controlling for the interaction effects between NMPOU and disability status. The interaction term (Non-Medical Prescription Opioid Use x Disabled) was statistically significant for all three measures of suicidality, even when controlling for the main effects in this interaction analysis.